WSI (KOSDAQ:A299170) - Share price, News & Analysis

A299170 fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	2/6
Financial Health	5/6
Dividends	0/6

A299170 Stock Overview

No business description

Rewards

Trading at 85.7% below our estimate of its fair value

Became profitable this year

Risk Analysis

High level of non-cash earnings

Shareholders have been diluted in the past year

Does not have a meaningful market cap (₩76B)

WSI Competitors

Price History & Performance

Summary of all time highs, changes and price drops for WSI
Historical stock prices
Current Share Price	₩2,530.00
52 Week High	₩3,515.00
52 Week Low	₩2,285.00
Beta	0
1 Month Change	-8.50%
3 Month Change	3.69%
1 Year Change	-15.67%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-26.24%

Shareholder Returns

	A299170	KR Healthcare	KR Market
7D	-5.8%	-4.6%	-1.8%
1Y	-15.7%	-43.5%	-15.2%

Return vs Industry: A299170 exceeded the KR Healthcare industry which returned -43.5% over the past year.

Return vs Market: A299170 matched the KR Market which returned -15.2% over the past year.

Price Volatility

Is A299170's price volatile compared to industry and market?
A299170 volatility
A299170 Average Weekly Movement	3.5%
Healthcare Industry Average Movement	5.7%
Market Average Movement	5.6%
10% most volatile stocks in KR Market	10.4%
10% least volatile stocks in KR Market	3.2%

Stable Share Price: A299170 is less volatile than 75% of KR stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: A299170's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	26	n/a	https://wsi-healthcare.com

WSI Fundamentals Summary

How do WSI's earnings and revenue compare to its market cap?
A299170 fundamental statistics
Market Cap	₩75.97b
Earnings (TTM)	₩7.17b
Revenue (TTM)	₩27.78b

10.6x

P/E Ratio

2.7x

P/S Ratio

Is A299170 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
A299170 income statement (TTM)
Revenue	₩27.78b
Cost of Revenue	₩17.59b
Gross Profit	₩10.18b
Other Expenses	₩3.01b
Earnings	₩7.17b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)	238.94
Gross Margin	36.66%
Net Profit Margin	25.83%
Debt/Equity Ratio	21.3%

How did A299170 perform over the long term?

See historical performance and comparison

Valuation

Is WSI undervalued compared to its fair value and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: A299170 (₩2530) is trading below our estimate of fair value (₩17677.38)

Significantly Below Fair Value: A299170 is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: A299170 is good value based on its PE Ratio (10.6x) compared to the Asian Healthcare industry average (18.1x).

PE vs Market: A299170 is good value based on its PE Ratio (10.6x) compared to the KR market (14.2x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate A299170's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: A299170 is overvalued based on its PB Ratio (2.3x) compared to the KR Healthcare industry average (2.2x).

Future Growth

How is WSI forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

16.9%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as WSI has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has WSI performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

5.3%

Last years revenue growth

Earnings and Revenue History

Quality Earnings: A299170 has a high level of non-cash earnings.

Growing Profit Margin: A299170 became profitable in the past.

Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if A299170's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: A299170 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: A299170 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (34.8%).

Return on Equity

High ROE: A299170's Return on Equity (21.5%) is considered high.

Financial Health

How is WSI's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: A299170's short term assets (₩47.6B) exceed its short term liabilities (₩18.0B).

Long Term Liabilities: A299170's short term assets (₩47.6B) exceed its long term liabilities (₩1.1B).

Debt to Equity History and Analysis

Debt Level: A299170 has more cash than its total debt.

Reducing Debt: Insufficient data to determine if A299170's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: A299170's debt is well covered by operating cash flow (83.6%).

Interest Coverage: A299170's interest payments on its debt are well covered by EBIT (12.1x coverage).

Balance Sheet

Dividend

What is WSI current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate A299170's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A299170's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if A299170's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A299170's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A299170 has not reported any payouts.

Next Steps

Explore strong dividend paying companies in the Healthcare industry.

Management

How experienced are the management team and are they aligned to shareholders interests?

CEO

WSI has no CEO, or we have no data on them.

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.7%.

Data	Last Updated (UTC time)
Company Analysis	2022/05/15 00:00
End of Day Share Price	2022/05/13 00:00
Earnings	2021/12/31
Annual Earnings	2021/12/31